Skip to main content

Table 1 Characteristics of all the included studies

From: Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis

Author Year Country Study design Stage Treatment Patients (n) Median age (range) RT doses (Gy) Chemotherapy
Naik et al. 2016 India Prospective IIA-IIIB IMRT 20 48(28–70) 50 cisplatin
3D 20 45(30–75)
Wu et al. 2016 Taiwan. Retrospective IB1-IVB IMRT 30 80.5 (75–88) 45–50.4 cisplatin
2D/3D 30 77.8 (75–88)
Ganhdi et al. 2013 India Prospective IIB-IIIB IMRT 22 50(36–65) 50.4 cisplatin
2D 22 45(36–65)
Chen et al. 2013 Taiwan Retrospective IB2-IIIB IMRT 83 54 45 cisplatin
2D/3D 237 54
Du et al. 2012 China Retrospective IIB-IIIB IMRT 60 52(31–74) 45–50 cisplatin
2D 62 55(26–77)
Kidd et al. 2010 USA Prospective IA2-IVB IMRT 135 52 50 cisplatin
2D/3D 317 52
  1. n number of patients, RT Radiotherapy, 2D Two-dimensional, 3D Three-dimensional, IMRT Intensity modulated RT